Farahani P, Khan S, Oatway M, Dziarmaga A. EXPLORING THE DISTRIBUTION OF PRESCRIPTION FOR SULFONYLUREAS IN PATIENTS WITH TYPE 2 DIABETES ACCORDING TO CARDIOVASCULAR RISK FACTORS WITHIN A CANADIAN PRIMARY CARE SETTING. J Popl Ther Clin Pharmacol [Internet]. 2018 Nov. 6 [cited 2024 Nov. 19];22(3). Available from: https://mail.jptcp.com/index.php/jptcp/article/view/249